AbbVie
Utility Patent Applications
Last updated:
List of all AbbVie patents 191 in total
| Status | Patent |
|---|---|
Application | Utility: METHODS OF TREATMENT OF DISEASES IN WHICH IL-13 ACTIVITY IS DETRIMENTAL USING ANTI-IL-13 ANTIBODIES Filling date: 12 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF Filling date: 12 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS Filling date: 12 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: MEDICATION PACKAGING AND DISPENSING SYSTEM Filling date: 12 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF Filling date: 12 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR Filling date: 12 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: ANTI-CD40 ANTIBODY DRUG CONJUGATES Filling date: 12 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE Filling date: 12 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS Filling date: 12 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF Filling date: 12 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: PRODRUG MODULATORS OF THE INTEGRATED STRESS PATHWAY Filling date: 12 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS Filling date: 12 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: Anti-EGFR Antibody-Drug Conjugates Filling date: 12 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: ENZYME COMPOSITIONS WITH REDUCED VIRAL AND MICROBIAL CONTAMINATION Filling date: 12 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: BICYCLIC PYRAZOLE BRUTON'S TYROSINE KINASE INHIBITORS Filling date: 12 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR Filling date: 12 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: METHODS OF TREATING PARKINSON'S DISEASE Filling date: 12 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: SOLID DISPERSIONS CONTAINING AN APOPTOSIS-INDUCING AGENT Filling date: 12 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: MODULATORS OF THE INTEGRATED STRESS PATHWAY Filling date: 12 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: METHODS OF TREATING HEAVY MENSTRUAL BLEEDING Filling date: 12 Sep 2025 Issue date: 17 Mar 2022 |
Application | Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF Filling date: 12 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: METHODS FOR TREATING SPINAL CORD INJURY AND PAIN Filling date: 12 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: WEARABLE AUTOMATIC INJECTION DEVICE FOR CONTROLLED ADMINISTRATION OF THERAPEUTIC AGENTS Filling date: 12 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: ANTI-ALPHA-4-BETA-7 ANTIBODIES Filling date: 12 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: Bromodomain Inhibitors Filling date: 12 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Filling date: 12 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: MODULATORS OF THE INTEGRATED STRESS PATHWAY Filling date: 12 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: Methods of Treating Acute HCV Filling date: 12 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: SYRINGE WITH TWO-STAGE SEALING PRESSURE Filling date: 12 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: METHODS OF TREATMENT OF DISEASES IN WHICH IL-13 ACTIVITY IS DETRIMENTAL USING ANTI-IL-13 ANTIBODIES Filling date: 12 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF Filling date: 12 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS Filling date: 12 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: MODULATORS OF THE INTEGRATED STRESS PATHWAY Filling date: 12 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Filling date: 12 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF Filling date: 12 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: PROLACTIN RECEPTOR BINDING PROTEINS AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: Dosing Regimens for Elagolix Filling date: 12 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE Filling date: 12 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: METHODS OF TREATING HEAVY MENSTRUAL BLEEDING Filling date: 12 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: Methods of Administering Elagolix Filling date: 12 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: MODULATORS OF THE INTEGRATED STRESS PATHWAY Filling date: 12 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: BISPECIFIC BINDING MOLECULES Filling date: 12 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: Bromodomain Inhibitors Filling date: 12 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITE DEGENERATION Filling date: 12 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: BROMODOMAIN INHIBITORS Filling date: 12 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: PRODRUG MODULATORS OF THE INTEGRATED STRESS PATHWAY Filling date: 12 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: TREATING SPONDYLOARTHRITIC AND PSORIATIC CONDITIONS WITH UPADACITINIB Filling date: 12 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Filling date: 12 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: ANTIBODIES AGAINST THE RGM A PROTEIN AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 29 Jul 2021 |
Showing 1 to 50 of 191 patents.